Qualigen (QLGN) Stock Rockets on Crypto Pivot – But Experts Warn It’s a Risky Bet
Qualigen Therapeutics shares surged over 100% in pre-market trading Oct. 24 after announcing a $30 million crypto treasury partnership with BitGo. The stock briefly touched $7 before settling in the mid-$5 range. Analysts flagged weak fundamentals and ongoing losses despite the rally. Qualigen remains a pre-revenue biotech with its lead drug still in early trials.
